NCT00825396已完成不适用
A Pilot, Open-Label, Controlled Clinical Trial of C-KAD Ophthalmic Solution in Reducing Intraocular Pressure in Patients With Ocular Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- Mean change in intraocular pressure from baseline
研究概览
简要总结
The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
- •Both eyes having best corrected visual acuity better than 20/50
排除标准
- •Advanced glaucoma
- •Closed or barely open anterior chamber or history of angle closure
研究组 & 干预措施
C-KAD Ophthalmic Solution
Experimental
干预措施: C-KAD Ophthalmic Solution (Drug)
结局指标
主要结局
Mean change in intraocular pressure from baseline
时间窗: 150 Days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related CataractCataractNCT00793091Chakshu Research, Inc.80
Unknown
2 期
Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear CataractNuclear CataractNCT00825721Chakshu Research, Inc.81
Unknown
2 期
An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid HyalosisAsteroid HyalosisNCT00825942Chakshu Research, Inc.20
已完成
1 期
Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10XProliferative Diabetic Retinopathy (PDR)NCT01869933OcuCure Therapeutics, Inc.10
已完成
3 期
Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy VolunteersAllergic ConjunctivitisNCT01159015Bausch & Lomb Incorporated534